Tetsuya Shindo
Publication Activity (10 Years)
Years Active: 2018-2024
Publications (10 Years): 15
Publications (10 Years): 15
Publications
- Toshiaki Tanaka, Koji Yamasaki, Seisuke Nofuji, Takeshi Maehana, Tetsuya Shindo, Yuki Kyoda, Kohei Hashimoto, Ko Kobayashi, Naoya Masumori
- Yuki Kyoda, Kosuke Shibamori, Tetsuya Shindo, Takeshi Maehana, Kohei Hashimoto, Ko Kobayashi, Toshiaki Tanaka, Fumimasa Fukuta, Naoya Masumori
- Toshiaki Tanaka, Koji Yamasaki, Seisuke Nofuji, Takeshi Maehana, Tetsuya Shindo, Yuki Kyoda, Kohei Hashimoto, Ko Kobayashi, Naoya Masumori
- Tetsuya ShindoEditorial Comment to J-AVENUE: A retrospective, real-world study evaluating patient characteristics and outcomes in patients with advanced urothelial carcinoma treated with avelumab first-line maintenance therapy in Japan. International journal of urology : official journal of the Japanese Urological Association (2024)
- Yuki Kyoda, Kosuke Shibamori, Tetsuya Shindo, Takeshi Maehana, Kohei Hashimoto, Ko Kobayashi, Toshiaki Tanaka, Fumimasa Fukuta, Naoya Masumori
- Toshiaki Tanaka, Koji Yamasaki, Seisuke Nofuji, Takeshi Maehana, Tetsuya Shindo, Yuki Kyoda, Kohei Hashimoto, Ko Kobayashi, Naoya Masumori
- Tetsuya ShindoEditorial Comment to J-AVENUE: A retrospective, real-world study evaluating patient characteristics and outcomes in patients with advanced urothelial carcinoma treated with avelumab first-line maintenance therapy in Japan. International journal of urology : official journal of the Japanese Urological Association 31 (8) (2024)
- Hidetoshi Tabata, Toshiaki Tanaka, Tetsuya Shindo, Kohei Hashimoto, Ko Kobayashi, Naoya Masumori
- Keiko Fujino, Tetsuya Shindo, Shiro Hinotsu, Naoya Masumori
- Toshiaki Tanaka, Tetsuya Shindo, Kohei Hashimoto, Ko Kobayashi, Naoya Masumori
- Tetsuya Shindo, Takeshi Maehana, Toshiaki Tanaka, Kohei Hashimoto, Ko Kobayashi, Atsushi Takahashi, Hiroshi Hotta, Yasuharu Kunishima, Keisuke Taguchi, Hitoshi Tachiki, Naoki Ito, Masanori Matsukawa, Ryuichi Kato, Shintaro Miyamoto, Shiro Hinotsu, Naoya MasumoriAre there differences in the characteristics of patients who respond to gemcitabine plus cisplatin chemotherapy and those who respond to pembrolizumab therapy for metastatic urothelial carcinoma? Multicenter retrospective study. International journal of urology : official journal of the Japanese Urological Association 29 (9) (2022)
- Tetsuya Shindo
- Tetsuya Shindo, Kohei Hashimoto, Toshiaki Tanaka, Keisuke Taguchi, Atsushi Takahashi, Naoki Itoh, Manabu Okada, Hiroshi Hotta, Yasuharu Kunishima, Takaoki Hirose, Masanori Matsukawa, Hitoshi Tachiki, Ryuichi Kato, Shiro Hinotsu, Naoya Masumori
- Tetsuya Shindo, Megumi Hirobe, Yasushi Adachi, Yasushi Sasaki, Takashi Tokino, Naoya Masumori
- Tetsuya Shindo, Ko Kobayashi, Toshiaki Tanaka, Naoya Masumori